EP1383473A2 - Cosmetic and dermatological preparations comprising a hop extract or hop-malt extract and their use for reducing the sebum content of the skin - Google Patents

Cosmetic and dermatological preparations comprising a hop extract or hop-malt extract and their use for reducing the sebum content of the skin

Info

Publication number
EP1383473A2
EP1383473A2 EP02740431A EP02740431A EP1383473A2 EP 1383473 A2 EP1383473 A2 EP 1383473A2 EP 02740431 A EP02740431 A EP 02740431A EP 02740431 A EP02740431 A EP 02740431A EP 1383473 A2 EP1383473 A2 EP 1383473A2
Authority
EP
European Patent Office
Prior art keywords
hop
skin
sebum
cosmetic
malt extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02740431A
Other languages
German (de)
French (fr)
Inventor
Stefan Gallinat
Andreas Herpens
Helga Biergiesser
Kirsten Venzke
Franz STÄB
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP1383473A2 publication Critical patent/EP1383473A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/008Preparations for oily hair

Definitions

  • the present invention relates to the use of topical preparations for reducing sebum production, for maintaining normal sebum homeostasis, for removing sebum from the skin, in particular for removing and clarifying comedones, for preventing comedone formation, for reducing pore size, for prophylaxis and for treatment seborrhea and blemished skin, for the treatment of mild forms of acne as well as against oily hair and dandruff.
  • Sebum is the secretion of the sebum gland. Sebaceous glands are bulges of the follicular epithelium and therefore part of the follicle with which they form a functional unit. They are holocrine glands, which means that the entire glandular cell is largely converted into the sebum secretion. The cells of the sebum gland, which are constantly renewed from below, become fat and disintegrate, and the skin sebum thus formed is emptied onto the surface of the skin through the follicle openings.
  • This surface film is an emulsion, which can be a water-in-oil or an oil-in-water emulsion. It has the function to keep the skin surface supple and to regulate the water content of the deep-lying skin layers. With good hydration of the sebum, the water content is at least 10 to 20% by weight and the sebum is hydrophilic. If the hydrophilic-hpophile balance of the surface film is no longer present and the water content drops, this is how the sebum changes and becomes hydrophobic. The outflow of sebum from the sebaceous gland and follicle is obstructed. Skin sebum stagnates in the follicular mouths, which can then lead to comedones and inflammation of the follicles
  • comedone formation can have various causes.
  • external influences such as incorrect cleaning habits and incorrect care, comedogenic substances in cosmetics, weather influences, alkaline soaps, harsh detergents.
  • An increased sebum gland secretion and the formation of comedones can also develop through genetic factors and hormonal influences
  • comedones, inflammation, pre-acne and acne with their after-effects can result
  • non-soap surfactants in the form of washing creams or washing lotions are mainly used for skin cleansing.
  • These syndets do not form lime soaps, but treatment with highly surface-active agents has an effect on them
  • Skin has a stronger degreasing and drying effect than soap
  • the more frequently soap and surfactant-containing products are used on the skin the clearer are their adverse effects, namely degreasing and drying out the skin by destroying the hy dro-lipid film in the foreground Almost always, the reduction of the comedones leads to a lowering of the water content in the upper layers of the skin and to a firm formation of concrements in the sebaceous glands, which in turn can induce inflammation.
  • the lowering of the moisture content of the skin is, however, for a caring removal of the Comedones counterproductive
  • Seborrhea is an increased function of the sebaceous glands due to predisposition. Both the scalp and facial skin appear greasy. The composition of seborrhoeic sebum is different from that of normal sebum. There are 3 stages of seborrhea development. 1 Simple seborrhea. Light cases, greasy after 8 days
  • Irreversible form is irreversible. Seborrhea, in which the hair looks bathed in fat after just one day The excessive secretion of the sebaceous glands can be triggered by, among other things, androgenetic disorders and has an aesthetic disadvantage on the overall appearance of the hair. This disorder can also be the cause of hair loss. Its precursor is the seborrhoeic condition of the scalp. Vegetative disorders and improper care can do this Skin condition and hair condition worsen Even with seborrhea, hair can be dry even due to keratin build-up. Dry, damaged hair is often caused by external stress such as sun or chemical treatments. Too hot blow drying or improper care of damaged hair can cause damage to lead
  • the causes of oily hair are in the human body and are caused by hormones.
  • Each hair has its own sebum gland that produces fat (sebum, sebum).
  • Sebum production is hormonally controlled and, depending on the hormone sensitivity of the sebum gland, it can cause an overuse - or come underproduction
  • the sebum itself has the function of keeping the scalp supple.It arrives from the sebum gland on the scalp and only later the hairline where it is normally absorbed by the hair shaft and remains invisible. In a sebum production the hair shaft is no longer able to do so It is visible as a greasy film on the hair. The result is streaky, greasy shiny hair
  • the treatment of seborrhea includes regular and thorough head washing with special shampoos, which can be carried out as often as necessary.
  • the wash should be combined with a massage in the connective tissue, because it empties sebum glands more, which delays re-greasing
  • the object of the present invention is to provide a preparation which does not have the disadvantages of the known and previously used agents, which has a sebum-reducing, fat-regulating and nourishing effect at the same time, removes the already existing comedones without irritation, degreasing and drying out effectively prevents the skin, which brings homeostasis of sebum secretion to a normal state, prevents the formation of comedones and the development of inflammatory skin symptoms, causes a reduction in pore size and is effective in the prophylaxis before and treatment of acne, as well as existing skin inflammation is improved and equivalent cares for the skin
  • This object is achieved by the use of a hop or Hop-malt extract for the preparation of preparations for reducing the production of sebum dissolved.
  • the active ingredients used according to the invention prevent the formation of seborrheic phenomena, in particular greasy hair, but also dandruff, and to eliminate existing seborrheic phenomena, in particular greasy hair, but also dandruff.
  • a method for the prophylaxis against and treatment of impure skin for reducing the pore size, mild forms of acne, inflammatory skin conditions or seborrheic symptoms, in particular oily hair and / or dandruff, is characterized in that the active ingredients used according to the invention are characterized in that a suitable cosmetic or dermatological carrier to be brought into contact with the area affected by increased sebum production.
  • a further preferred embodiment of the present invention are therefore formulations to be used against dandruff, for example antidandruff shampoos.
  • the active ingredients are preferably used in cosmetic or dermatological compositions with a content of 0.0005-50.0% by weight, in particular 0.01-20.0% by weight, based on the total weight of the composition, being preferred.
  • the compositions advantageously contain 0.02-10.0% by weight, particularly preferably 0.02-5.0% by weight of the active ingredients used according to the invention, very particularly advantageously 0.1-3.0% by weight, each based on the total weight of the composition.
  • agents which act against sebum for example selected from the group of starch phosphate, cyclodextrin, sodium um maize starch octylene succinate, silica-dimethyl silylate, hydroxypropyl distarch phosphate, tapioca dextrin, aluminum Starch octylene succinate, acrylate copolymer, magnesium carbonate, maize starch, aluminum starch octylene succinate, kaolin, nylon (eg nylon 6/12), bentonite, sodium silicoaluminate, boron nitride, silica, mica + titanium dioxide.
  • the active compounds according to the invention for. B. as a so-called solid lipid nanoparts with the help of melted waxes, which, among other things, but not exclusively, can be selected from the group of ester waxes, triglyceride waxes or hydrocarbon waxes.
  • the active ingredients used according to the invention can be incorporated into common cosmetic or dermatological formulations without difficulty, advantageously in pump sprays, aerosol sprays, creams, ointments, tinctures, lotions, sticks, washing products and the like.
  • active substances used according to the invention with other active substances, for example with other antimicrobial, antimycotic or antiviral substances.
  • compositions according to the invention can be buffered.
  • a pH range from 3.0 to 9.0 is advantageous. It is particularly favorable to choose the pH in a range from 4.0 to 6.5.
  • the cosmetic and / or dermatological formulations according to the invention can be composed as usual and can be used to treat the skin and / or the hair in the sense of a dermatological treatment or a treatment in the sense of nourishing cosmetics. They can also be used in make-up products in decorative cosmetics
  • the cosmetic and / or dermatological formulations according to the invention are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics and dermatics
  • the antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and its derivatives (eg anserine), carotenoids, carotenes (eg ⁇ -carotene, ⁇ -carotene, lycopene, phytoene) and their derivatives, lipoic acid and its derivatives (eg dihydro-ponic acid), aurothioglucose, Propylthiouracil and other thiols (e.g.
  • amino acids eg glycine, histidine, tyrosine, tryptophan
  • imidazoles eg urocanic acid
  • peptides such as D, L-carnosine, D-carnosine, L-
  • thioredoxin glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl) , Oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds ( z. B.
  • Buthioninsulfoximine Homocyste- insulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathi oninsulfoximine
  • very low contractual doses e.g. pmol to ⁇ mol / kg
  • also (metal) chelators e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactofer n
  • ⁇ -hydroxy acids e.g.
  • citric acid citric acid, lactic acid, Malic acid
  • tetrahydrocurcumin humic acid
  • bile acid bile extracts
  • bihrubin biliverdin
  • EDTA EDTA
  • EGTA EGTA
  • unsaturated fatty acids and their derivatives e.g. ⁇ -linolenic acid, linoleic acid, oleic acid
  • folic acid and their derivatives unsaturated fatty acids and their derivatives (e.g. ⁇ -linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, alanine diacetic acid, polylaphenol diacid, poly Catechins, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g.
  • vitamin E acetate vitamin E acetate
  • coniferyl benzoate of benzoic resin ruthenic acid and its derivatives, ferulic acid and its derivatives, Butylhydroxyto-toluene, butylhydroxyanisole, nordihydroguajakharzsaure, nordihydroguajaretsaure, tri- hydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (eg ZnO, ZnSO 4 ) selenium and its derivatives (eg selenium methionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances
  • the amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation
  • the prophylaxis or the cosmetic or dermatological treatment with the active ingredient used according to the invention or with the cosmetic or topical dermatological preparations with an effective content of active ingredient used according to the invention is carried out in the customary manner, in such a way that the active ingredient used according to the invention or the cosmetic or topical dermatological preparations with an effective content of active ingredient used according to the invention is applied to the affected skin areas
  • the active ingredient used according to the invention can advantageously be incorporated into conventional cosmetic and dermatological preparations, which can be in various forms.
  • they can be a solution, an emulsion of the water-in-oil (W / O) type or of the oil-in type.
  • Emulsions according to the invention in the sense of the present invention are advantageous and contain, for example, fats, oils, waxes and / or other fatty substances, as well as water and one or more emulsifiers such as them commonly used for such a type of formulation
  • Medical topical compositions in the sense of the present invention generally contain one or more medicaments in an effective concentration.
  • medicaments in an effective concentration.
  • Preparations according to the invention can therefore advantageously contain substances which absorb UV radiation in the UVB range, the total amount of filter substances e.g. 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1 to 6% by weight, based on the total weight of the preparations.
  • the total amount of filter substances e.g. 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1 to 6% by weight, based on the total weight of the preparations.
  • the UVB filters can be oil-soluble or water-soluble.
  • oil-soluble substances e.g. to call:
  • 3-benzylidene camphor and its derivatives for example 3- (4-methylbenzylidene) camphor, 4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester;
  • Esters of cinnamic acid preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;
  • esters of salicylic acid preferably salicylic acid (2-ethylhexyl) ester, salicylic acid (4-isopropylbenzyl) ester, salicylic acid homomethyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • Esters of benzalmalonic acid preferably 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester;
  • 2-phenylbenzimidazole-5-sulfonic acid and its salts e.g. Sodium, potassium or triethanolammonium salts
  • Sulfonic acid derivatives of benzophenones preferably 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid and their salts;
  • Sulfonic acid derivatives of 3-benzylidene camphor e.g. 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid, 2-methyl-5- (2-pxo-3-bornylidenemethyl) sulfonic acid and their salts.
  • UVB filters which can be used according to the invention, is of course not intended to be limiting.
  • UVA filters in the preparations according to the invention, which are usually contained in cosmetic and / or dermatological preparations.
  • Such filter substances are preferably derivatives of dibenzoylmethane, in particular 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione and 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione. Preparations containing these combinations are also the subject of the invention.
  • the same amounts of UVA filter substances that were mentioned for UVB filter substances can be used.
  • Cosmetic and / or dermatological preparations in the sense of the present invention can also contain inorganic pigments which are usually used in cosmetics. Metics to protect the skin from UV rays are used. These are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, and modifications in which the oxides are the active agents are particularly preferred the pigments are based on titanium dioxide. The amounts mentioned for the above combinations can be used
  • the cosmetic and dermatological preparations used in accordance with the invention can contain cosmetic active ingredients, auxiliaries and / or additives of the kind normally used in such preparations, for example antioxidants, preservatives, bactericides, perfumes, substances for preventing foaming, dyes, pigments , which have a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing substances, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic Solvents or silicon derivatives
  • the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, solvents can be used
  • Oils such as Tnglyce ⁇ de the Cap ⁇ n- or the caprylic acid, but preferably castor oil, fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low C number, for example with isopropanol, propylene glycol or Glycenn, or esters of Fatty alcohols with low C number alkane acids or with fatty acids,
  • Alcohols, diols or polyols of low C number, and their ethers preferably ethanol, isopropanol, propylene glycol, glycene, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or
  • the oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions for the purposes of the present invention is advantageously selected from the group of esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 carbon atoms.
  • ester oils can then advantageously be chosen from the group of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononylisononanoate, 2-ethyl-2-ethylhexyl, ethyl-2-ethylhexyl, ethyl-2-ethylhexyl 2- octyldodecyl palmitate, oleyl oleate, olerlerucate, erucyl oleate, erucylerucate as well as synthetic, semi-synthetic and natural mixtures of such esters, for example jojoba oil.
  • the oil phase can advantageously be selected from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and also the fatty acid triglycerides, especially the triglycne esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 - 18 carbon atoms.
  • the fatty acid triglycerides can, for example, advantageously be selected from the group of synthetic, semisynthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
  • any mixtures of such oil and wax components can also be used advantageously for the purposes of the present invention. It may also be advantageous to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.
  • the oil phase is advantageously selected from the group consisting of 2-ethylhexyl isostearate, octyldecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C 12 . 15 alkyl benzoate, caprylic capric acid triglyceride, dicaprylyl ether.
  • hydrocarbons paraffin oil, squalane and squalene are advantageously used in the context of the present invention.
  • the oil phase can advantageously also contain cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or the silicone oils.
  • Cyclomethicone (octamethylcyclotetrasiloxane) is advantageously used as the silicone oil to be used according to the invention.
  • other silicone oils can also be used advantageously for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
  • the aqueous phase of the preparations according to the invention advantageously advantageously contains alcohols, diols or polyols of low C number, and also their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether , Diethylenglykolmonomethyl- or -monoethylether and analogous products, furthermore low C-number alcohols, eg Ethanol, isopropanol, 1, 2-propanediol, glycerol and in particular one or more thickeners, which one or more can advantageously be selected from the group consisting of silicon dioxide, aluminum silicates, polysaccharides or their derivatives, e.g.
  • Hyaluronic acid, xanthan gum, hydroxypropyl methyl cellulose particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called carbopols, for example carbopoles of types 980, 981, 1382, 2984, 5984, each individually or in combination.
  • carbopols for example carbopoles of types 980, 981, 1382, 2984, 5984, each individually or in combination.
  • Gels used according to the invention usually contain alcohols of low C number, for example ethanol, isopropanol, 1, 2-propanediol, glycerol and water or an oil mentioned above in the presence of a thickener which is used in the case of oily alcoholic len is preferably silicon dioxide or an aluminum silicate, in the case of aqueous-alcoholic or alcoholic gels it is preferably a polyacrylate.
  • alcohols of low C number for example ethanol, isopropanol, 1, 2-propanediol, glycerol and water or an oil mentioned above in the presence of a thickener which is used in the case of oily alcoholic len is preferably silicon dioxide or an aluminum silicate, in the case of aqueous-alcoholic or alcoholic gels it is preferably a polyacrylate.
  • Fixed pens contain e.g. natural or synthetic waxes, fatty alcohols or fatty acid esters.
  • liquid oils for example paraffin oils, castor oil, isopropyl myristate
  • semi-solid components for example petroleum jelly, lanolin
  • solid components for example beeswax, ceresin and microcrystallines
  • Waxes or ozokerite for example beeswax, ceresin and microcrystallines
  • high-melting waxes e.g. carnauba wax, candelilla wax
  • Suitable blowing agents for cosmetic and / or dermatological preparations which can be sprayed from aerosol containers for the purposes of the present invention are the customary known volatile, liquefied blowing agents, for example hydrocarbons (propane, butane, isobutane), which can be used alone or in a mixture with one another. Compressed air can also be used advantageously.
  • hydrocarbons propane, butane, isobutane
  • Cosmetic preparations in the sense of the present invention can also be present as gels which, in addition to an effective content of the active ingredient according to the invention and solvents usually used for this purpose, preferably water, and also organic thickeners, for example gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, Hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or inorganic thickeners, e.g. B. aluminum silicates such as bentonite, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate.
  • organic thickeners for example gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, Hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or inorganic thickeners, e.g. B. aluminum silicates such as benton
  • the thickener is contained in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15% by weight.
  • the following examples are intended to illustrate the embodiment of the present invention. The information always refers to% by weight, unless other information is given.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the utilization of a hop extract or hop-malt extract for producing preparations used for reducing the production of sebum and/or for regulating a normal sebum homeostasis as well as for the prophylaxis and treatment of acne, unclean skin, oily hair and dandruff.

Description

Beschreibung description
Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Hopfenbzw. Hopfen-Malz-Extrakt und Verwendung eines Hopfen- bzw. Hopfen-Malz- Extraktes zur Herstellung kosmetischer und dermatologischer Zubereitungen zur Reduktion des Sebumgehaltes der HautCosmetic and dermatological preparations containing hop or Hop-malt extract and use of a hop or hop-malt extract for the production of cosmetic and dermatological preparations for reducing the sebum content of the skin
Die vorliegende Erfindung betrifft die Verwendung von topischen Zubereitungen zur Reduktion der Sebumproduktion, zum Erhalt der normalen Sebumhomeostase, zur Entfernung von Sebum von der Haut, insbesondere zur Beseitigung und Klärung von Comedonen, zur Vermeidung von Comedonenbildung, zur Reduktion der Porengröße, zur Prophylaxe und Behandlung der Seborrhöe und unreiner Haut, zur Behandlung leichter Formen der Akne sowie gegen fettige Haare und Kopfschuppen.The present invention relates to the use of topical preparations for reducing sebum production, for maintaining normal sebum homeostasis, for removing sebum from the skin, in particular for removing and clarifying comedones, for preventing comedone formation, for reducing pore size, for prophylaxis and for treatment seborrhea and blemished skin, for the treatment of mild forms of acne as well as against oily hair and dandruff.
Talgdrüsenüberproduktion und die möglichen sich daraus entwickelnden Hautstörungen wie Talgretention, Ausbildung von Comedonen im Gebiet der Talgdrüsen, also im Gesicht (vor allem Stirn, Nase und Kinn) und auf dem oberen Rücken, sind häufig anzutreffende Hautprobleme, die bisher nicht in zufriedenstellendem Masse gelöst worden sind.Sebaceous gland overproduction and the possible resulting skin disorders such as sebum retention, formation of comedones in the area of the sebaceous glands, i.e. in the face (especially forehead, nose and chin) and on the upper back, are common skin problems that have not yet been solved to a satisfactory extent are.
Talg ist das Sekret der Talgdrüse. Talgdrüsen sind Ausbuchtungen des Follikelepithels und damit Bestandteile des Follikels, mit dem sie eine funktionelle Einheit bilden. Sie sind holokrine Drüsen, das bedeutet, die ganze Drüsenzelle wird zum größten Teil in das Sekret Talg umgewandelt. Die Zellen der Talgdrüse, die von unten her ständig er- neuert werden, verfetten und zerfallen, und der so gebildete Hauttalg wird durch die Follikelmündungen auf die Hautoberflache entleert.Sebum is the secretion of the sebum gland. Sebaceous glands are bulges of the follicular epithelium and therefore part of the follicle with which they form a functional unit. They are holocrine glands, which means that the entire glandular cell is largely converted into the sebum secretion. The cells of the sebum gland, which are constantly renewed from below, become fat and disintegrate, and the skin sebum thus formed is emptied onto the surface of the skin through the follicle openings.
Der Hauttalg besteht nach G. Leonardy (J.Ft. Jellinek Kosmetologie, Zweck und Aufbau kosmetischer Präparate, Dr. Alfred Hüthig-Verlag, Heidelberg - Mainz - Basel, dritter völlig überarbeiteter und wesentlich erweiterte Auflage 1976, Seiten 26 bis 29) aus Mono-, Di- und Triglyce den (C10-C18), Wachsen (C16-C26), Wachsestern (C28-C38), normalen gesattigten Fettsauren (Cι0-C18), verzweigtkettigen gesattigten Fettsauren (Cn-C18), mehrfach verzweigtkettigen gesattigten Fettsauren (C13-C18), einfach ungesättigten Fettsauren (Cn-C18), mehrfach ungesättigten Fettsauren (C13, C15-C17), Ste- rolen (Cholesteπn, 7-Dehydrocholesterιn, 7-Hydroxycholesterιn), verzweigten und un- verzweigten Kohlenwasserstoffen (C3o-C4o), Squalen und Phospho pidenThe skin sebum exists after G. Leonardy (J.Ft. Jellinek cosmetology, purpose and structure of cosmetic preparations, Dr. Alfred Hüthig-Verlag, Heidelberg - Mainz - Basel, third completely revised and significantly expanded edition 1976, pages 26 to 29) from mono-, di- and triglyce (C 10 -C 18 ), waxes (C 16 -C 26 ), wax esters (C 2 8-C 38 ), normal saturated fatty acids (Cι 0 -C 18 ), branched-chain saturated fatty acids (Cn-C 18 ), polybranched saturated fatty acids (C 13 -C 18 ), monounsaturated fatty acids (Cn-C 18 ), polyunsaturated fatty acids (C 13 , C 15 -C 17 ), sterols (Cholesteπn, 7 -Dehydrocholesterιn, 7-hydroxycholesterιn), branched and unbranched hydrocarbons (C 3 oC 4 o), squalene and phosphopiden
Zusammen mit dem wassπgen Sekret der ekkπnen Schweißdrusen bilden die Lipide der Talgdruse den sogenannten Hydro-Lipid-Film der Haut Dieser Oberflachenfilm ist eine Emulsion, die eine Wasser-in-öl oder eine ÖI-in-Wasser-Emulsion sein kann Sie hat die Funktion, die Hautoberflache geschmeidig zu halten und den Wassergehalt der tieferhegenden Hautschichten zu regeln Bei guter Hydratation des Sebums betragt der Wassergehalt mindestens 10 bis 20 Gew -% und das Sebum ist hydrophil Ist das hydrophil-hpophile Gleichgewicht des Oberflachenfilmes nicht mehr gegeben und der Wassergehalt sinkt, so verändert sich das Sebum und wird hydrophob Der Talg- abfluss aus Talgdruse und Follikel wird behindert Es kommt zu einer Stauung des Hauttalgs in den Follikelmundungen, die dann in der Folge zu Comedonen und Entzündungen der Follikel fuhren kannTogether with the water secretion of the specific sweat glands, the lipids of the sebaceous glands form the so-called hydro-lipid film of the skin. This surface film is an emulsion, which can be a water-in-oil or an oil-in-water emulsion. It has the function to keep the skin surface supple and to regulate the water content of the deep-lying skin layers. With good hydration of the sebum, the water content is at least 10 to 20% by weight and the sebum is hydrophilic. If the hydrophilic-hpophile balance of the surface film is no longer present and the water content drops, this is how the sebum changes and becomes hydrophobic. The outflow of sebum from the sebaceous gland and follicle is obstructed. Skin sebum stagnates in the follicular mouths, which can then lead to comedones and inflammation of the follicles
Die Veränderung des Hauttalgs und das Einleiten der Comedonenbildung kann verschiedene Ursachen haben Zum Beispiel äußere Einflüsse, wie falsche Reinigungsgewohnheiten und falsche Pflege, comedogene Substanzen in Kosmetika, Witte- rungsemflusse, alkalische Seifen, scharfe Detergentien Eine vermehrte Talgdrusen- sekretion und die Ausbildung von Comedonen kann sich auch durch genetische Fak- toren und hormonelle Einflüsse entwickeln Auch hier können Comedonen, Entzündungen, Pra-Akne und Akne mit ihren Nachwirkungen die Folge seinThe change in skin sebum and the initiation of comedone formation can have various causes. For example, external influences, such as incorrect cleaning habits and incorrect care, comedogenic substances in cosmetics, weather influences, alkaline soaps, harsh detergents. An increased sebum gland secretion and the formation of comedones can also develop through genetic factors and hormonal influences Here, too, comedones, inflammation, pre-acne and acne with their after-effects can result
Die Häufigkeit der Hautschaden durch eine gestörte Talgdrusenfunktion und Krankheiten der Talgdrusen steigen immer mehr, und die Rückführung/Vermeidung der Comedonenbildung ist somit ein vordringliches Anliegen Doch bisherige Versuche, die Comedonenbildung als ein ursächliches Problem zu losen, haben zu wenig befriedigenden Ergebnissen gefuhrtThe frequency of skin damage due to impaired sebum gland function and diseases of the sebum glands is increasing more and more, and the return / avoidance of comedone formation is a matter of urgency. However, previous attempts to solve comedone formation as a causal problem have led to unsatisfactory results
Neben dem manuellen Entfernen der Comedonen durch Ausdrucken sind zahlreiche Reinigungsmethoden bekannt, mit denen versucht wird, Comedonen zu entfernen und die Comedonenbildung nachhaltig zu verhindern Hierzu gehören spezielle Seifen, hautabschalende Kompositionen und dergleichen Erweichende und adstnngierende Mittel finden ebenso Anwendung Daruberhinaus wird versucht, durch Zusatz von austrocknenden, keratolytischen, antiseborrhoischen und antibakteriellen Wirkstoffen in kosmetischen und pharmazeutischen Zubereitungen die Neigung zur Akne zu reduzieren, ohne daß sich Irritationen der Haut oder ein Austrocknen der Haut einstellenIn addition to the manual removal of the comedones by printing, numerous cleaning methods are known which attempt to remove comedones and Long-term prevention of comedone formation These include special soaps, skin-shelling compositions and the like. Softening and softening agents are also used. In addition, attempts are made to reduce the tendency to acne by adding drying, keratolytic, antiseborrheic and antibacterial agents in cosmetic and pharmaceutical preparations without skin irritation or drying out
Die Hautreinigung entfettet allerdings die Haut und entzieht ihr Feuchtigkeit Zusätzlich haben Seifen den Nachteil, daß die sich bei Verwendung der Seifen in hartem Wasser bildenden wasserunlöslichen Calcium- und Magnesiumsalze der höheren Fettsauren auf der Haut schleimige Niederschlage bilden Diese Niederschlage verbleiben bei schlechter Abspulbarkeit langer auf der Haut, verstopfen die Follikelmundungen und können zu einer Ausbildung von Comedonen fuhren Daher werden zur Hautreinigung vorwiegend Syndets (d h Tenside ohne Seifencharakter) in Form von Waschcremes oder Waschlotionen eingesetzt Diese Syndets bilden zwar keine Kalkseifen, aber die Behandlung mit stark oberflächenaktiv wirkenden Agentien hat auf die Haut eine starker entfettende und austrocknende Wirkung als Seife Je häufiger seifen- und tensid- haltige Produkte auf der Haut angewandt werden, desto deutlicher treten deren nachteilige Wirkungen, nämlich Entfettung und Austrocknung der Haut durch Zersto- rung des Hydro-Lipid-Filmes in den Vordergrund Fast immer fuhrt die Reduzierung der Comedonen zur Absenkung des Wassergehaltes in den oberen Hautschichten und zu einer festen Konkrementbildung in den Talgdrusen, die wiederum Entzündungen induzieren kann Die Absenkung des Feuchtigkeitsgehaltes der Haut ist aber für eine pflegende Entfernung der Comedonen kontraproduktivHowever, skin cleansing degreases the skin and removes moisture from it. In addition, soaps have the disadvantage that the water-insoluble calcium and magnesium salts of higher fatty acids that form in hard water form slimy precipitates on the skin when these soaps are used Skin, clog the follicular mouths and can lead to the formation of comedones.Therefore, syndets (i.e. non-soap surfactants) in the form of washing creams or washing lotions are mainly used for skin cleansing.These syndets do not form lime soaps, but treatment with highly surface-active agents has an effect on them Skin has a stronger degreasing and drying effect than soap The more frequently soap and surfactant-containing products are used on the skin, the clearer are their adverse effects, namely degreasing and drying out the skin by destroying the hy dro-lipid film in the foreground Almost always, the reduction of the comedones leads to a lowering of the water content in the upper layers of the skin and to a firm formation of concrements in the sebaceous glands, which in turn can induce inflammation. The lowering of the moisture content of the skin is, however, for a caring removal of the Comedones counterproductive
Seborrhoe ist eine gesteigerte Funktion der Talgdrusen durch Veranlagung Sowohl Kopfhaut als auch Gesichtshaut erscheinen fettig Die Zusammensetzung des se- borrhoeischen Sebums ist gegenüber dem normalen Sebum verändert man unterscheidet 3 Entwicklungsstufen der Seborrhoe 1 Einfache Seborrhoe Leichte Fälle, fettig nach 8 TagenSeborrhea is an increased function of the sebaceous glands due to predisposition. Both the scalp and facial skin appear greasy. The composition of seborrhoeic sebum is different from that of normal sebum. There are 3 stages of seborrhea development. 1 Simple seborrhea. Light cases, greasy after 8 days
2 ölige Seborrhoe Bereits nach 2-3 Tagen fettig2 oily seborrhea greasy after only 2-3 days
3 Irreversible Form nicht mehr umkehrbar Die Seborrhoe, bei der das Haar bereits nach einem Tag wie in Fett gebadet aussieht Die übermäßige Absonderung der Talgdrusen kann unter anderem durch androgene- tische Störungen ausgelost werden und hat einen ästhetischen Nachteil auf das Gesamtbild der Haare Diese Störung kann auch die Ursache für auftretenden Haarausfall sein Vorlaufer ist jeweils der seborrhoeische Zustand der Kopfhaut Vegetative Störungen sowie unsachgemäße Pflege können das Hautbild und auch den Haarzustand noch verschlechtern Auch bei Seborrhoe kann das Haar selbst durch Störungen im Keratinaufbau trocken sein Trockenes, angegriffenes Haar wird häufig hervorgerufen durch äußere Beanspruchung wie z B Sonne oder chemischen Behandlungen Zu heißes Fönen oder nicht richtige Pflege von angegriffenem Haar können zu Schädigungen fuhren3 Irreversible form is irreversible. Seborrhea, in which the hair looks bathed in fat after just one day The excessive secretion of the sebaceous glands can be triggered by, among other things, androgenetic disorders and has an aesthetic disadvantage on the overall appearance of the hair. This disorder can also be the cause of hair loss. Its precursor is the seborrhoeic condition of the scalp. Vegetative disorders and improper care can do this Skin condition and hair condition worsen Even with seborrhea, hair can be dry even due to keratin build-up. Dry, damaged hair is often caused by external stress such as sun or chemical treatments. Too hot blow drying or improper care of damaged hair can cause damage to lead
Die Ursachen für fettiges Haar liegen im Korper des Menschen und sind hormoneil bedingt Jedes Haar besitzt eine eigene Talgdruse, die Fett (Sebum, Hauttalg) produziert Die Sebum-Produktion wird hormoneil gesteuert, und es kann je nach Hormon- empfindlichkeit der Talgdruse zu einer Über- oder Unterproduktion kommen Der Talg selber hat die Funktion die Kopfhaut geschmeidig zu halten Er gelangt aus der Talgdruse auf die Kopfhaut und erst spater den Haaransatz Dort wird er normalerweise vom Haarschaft aufgenommen und bleibt unsichtbar Bei einer Talguberproduktion ist der Haarschaft nicht mehr in der Lage diesen aufzunehmen Er wird als Fettfilm am Haar sichtbar Die Folge ist strähniges, fettig glänzendes HaarThe causes of oily hair are in the human body and are caused by hormones. Each hair has its own sebum gland that produces fat (sebum, sebum). Sebum production is hormonally controlled and, depending on the hormone sensitivity of the sebum gland, it can cause an overuse - or come underproduction The sebum itself has the function of keeping the scalp supple.It arrives from the sebum gland on the scalp and only later the hairline where it is normally absorbed by the hair shaft and remains invisible. In a sebum production the hair shaft is no longer able to do so It is visible as a greasy film on the hair. The result is streaky, greasy shiny hair
Dadurch, daß die Talgdrusenproduktion vom Hormonhaushalt abhangig ist, laßt sich das Problem fettigen Haares nicht grundsätzlich losen, denn die Talgdrusen produzieren stetig Fett Konsequente Pflege und hochwertige Pflegesenen sind immer noch die beste Methode zur Bekämpfung fettigen HaaresBecause the sebum gland production is dependent on the hormone balance, the problem of greasy hair cannot be solved in principle, because the sebum glands constantly produce fat. Consistent care and high-quality nurses are still the best method to combat oily hair
Fettiges Haar hat sehr lastige Auswirkungen Die Haare werden schon kurze Zeit nach dem Waschen wieder strähnig und die Frisur halt nichtOily hair has very heavy effects. The hair becomes streaky again shortly after washing and the hairstyle does not hold
Entgegen landläufiger Meinung ist es nur ein Gerücht, daß durch zu häufiges Waschen das Haar noch schneller fettig wird Milde Shampoos gegen fettiges Haar sorgen dafür, daß übermäßiges Fett entfernt wird Haar und Kopfhaut werden mit ausreichend Feuchtigkeit versorgt und gleichen die Überproduktion der Talgdrusen aus Fettiges Haar und Schuppenbildung gehören zu den häufigsten Haarproblemen Diese Anomalien sind auf eine Störung der Talgdrusentatigkeit zurückzuführen Bei einer U- berfunktion der Talgdrusen sprechen wir von einer Seborrhoe Dabei sind zwei Formen zu unterscheiden die ölige Form (Seborrhoe oleosa) und die trockene Form (Se- borrhoe sicca )Contrary to popular belief, it is only a rumor that washing your hair too often makes it greasy more quickly. Mild shampoos for greasy hair ensure that excessive fat is removed. Hair and scalp are supplied with sufficient moisture and balance the overproduction of the sebum glands Oily hair and dandruff are among the most common hair problems. These abnormalities are due to a disruption of the sebaceous gland activity. If the sebaceous glands are overactive, we speak of seborrhea. There are two types: oily form (seborrhea oleosa) and dry form (se borrhoe sicca)
Die Seborrhoea oleosaSeborrhoea oleosa
Hier hegt eine Überfunktion der Talgdrusen vor, bei der die Talgdrusen zu viel und zu öligen Talg erzeugen Die Haut zeigt deshalb einen fettigen Glanz, und die Haare sind schon 2 bis 3 Tage nach der Wasche wieder bis in die Spitzen fettig und strähnigHere there is an overfunction of the sebaceous glands, in which the sebum glands produce too much and too oily sebum. The skin therefore shows an oily sheen, and the hair is greasy and streaky up to the tips just 2 to 3 days after washing
Die Seborrhoea siccaThe seborrhea sicca
Sie ist ebenfalls auf eine Überfunktion der Talgdrusen zurückzuführen, aber der Hauttalg ist trockener, er hat eine festere Konsistenz Mit den Schuppchen der Ober- haut bildet er große, leicht zerreibbare Talgschuppen Die Kopfhaut zeigt einen wachsartigen Glanz, das Haar fettet nur am Ansatz nach, die Langen und besonders die Spitzen sind trocken und sogar sprödeIt is also due to an overfunction of the sebum glands, but the skin sebum is drier, it has a firmer consistency. With the scales of the epidermis, it forms large, easily friable sebum scales. The scalp shows a wax-like shine, the hair only greases at the base, the long ones and especially the tips are dry and even brittle
Zur Behandlung der Seborrhoe gehört zunächst mal die regelmäßige und gründliche Kopfwasche mit Spezialshampoos, die so oft durchgeführt werden kann, wie es notig erscheint Die Wasche sollte mit einer Massage im Bindegewebe verbunden sein, weil dadurch dir Talgdrusen starker entleert werden, was die Nachfettung verzögertThe treatment of seborrhea includes regular and thorough head washing with special shampoos, which can be carried out as often as necessary.The wash should be combined with a massage in the connective tissue, because it empties sebum glands more, which delays re-greasing
Der vorliegenden Erfindung egt die Aufgabe zugrunde, eine Zubereitung zur Verfu- gung zu stellen, die die Nachteile der bekannten und bisher verwendeten Mittel nicht aufweist, die gleichzeitig talglosend, fettreguherend und pflegend wirkt, die bereits vorhandenen Comedonen ohne Irritationen entfernt, die Entfettung und Austrocknung der Haut wirksam verhindert, die eine Homeostase der Sebumsekretion auf einen Normalzustand bewirkt, die Comedonenbildung und die Entstehung von entzündlichen Hauterscheinungen verhindert, eine Reduktion der Porengroße bewirkt und die wirksam ist bei der Prophylaxe vor und Behandlung von Akne, sowie schon bestehende Hautentzündungen bessert und gleichwertig die Haut pflegtThe object of the present invention is to provide a preparation which does not have the disadvantages of the known and previously used agents, which has a sebum-reducing, fat-regulating and nourishing effect at the same time, removes the already existing comedones without irritation, degreasing and drying out effectively prevents the skin, which brings homeostasis of sebum secretion to a normal state, prevents the formation of comedones and the development of inflammatory skin symptoms, causes a reduction in pore size and is effective in the prophylaxis before and treatment of acne, as well as existing skin inflammation is improved and equivalent cares for the skin
Diese Aufgabe wird erfindungsgemaß durch die Verwendung eines Hopfen- bzw Hopfen-Malz-Extraktes zur Herstellung von Zubereitungen zur Verminderung der Produktion von Sebum gelöst.This object is achieved by the use of a hop or Hop-malt extract for the preparation of preparations for reducing the production of sebum dissolved.
Überraschenderweise wird bei Verwendung der Zubereitung die comedogene Wirkung der in der Zubereitung verwendeten Rohstoffe aufgehoben und damit die Bildung von Comedonen und entsprechend die Entstehung von Akne hervorgerufen durch kosmetische Inhaltsstoffeverhindert.Surprisingly, when using the preparation, the comedogenic effect of the raw materials used in the preparation is abolished and the formation of comedones and, accordingly, the development of acne caused by cosmetic ingredients are prevented.
Es hat sich ferner herausgestellt, daß die erfindungsgemäß verwendeten Wirkstoffe die Bildung von seborrhoischen Erscheinungen, insbesondere fettiges Haar, aber auch Kopfschuppen, verhindern sowie bereits vorhandene seborrhoische Erscheinungen, insbesondere fettiges Haar, aber auch Kopfschuppen, zu beseitigen.It has also been found that the active ingredients used according to the invention prevent the formation of seborrheic phenomena, in particular greasy hair, but also dandruff, and to eliminate existing seborrheic phenomena, in particular greasy hair, but also dandruff.
Erfindungsgemäß sind somit auch ein Verfahren zur Prophylaxe gegen und Behand- lung von unreiner Haut, zur Reduktion der Porengröße, leichter Formen der Akne, entzündlichen Hautzuständen oder seborrhoischen Erscheinungen, insbesondere fettigem Haar und/oder Kopfschuppen, dadurch gekennzeichnet, daß die erfindungsgemäß verwendeten Wirkstoffe in einem geeigneten kosmetischen oder dermatologischen Träger, mit dem von gesteigerte Sebumproduktion betroffenen Bereich in Kon- takt gebracht werden.According to the invention, a method for the prophylaxis against and treatment of impure skin, for reducing the pore size, mild forms of acne, inflammatory skin conditions or seborrheic symptoms, in particular oily hair and / or dandruff, is characterized in that the active ingredients used according to the invention are characterized in that a suitable cosmetic or dermatological carrier to be brought into contact with the area affected by increased sebum production.
Der Stand der Technik lieferte nicht den geringsten Hinweis auf die erfindungsgemäße Verwendung als antiseborrhoisches Wirkprinzip.The prior art did not provide the slightest indication of the use according to the invention as an antiseborrheic active principle.
Eine weitere bevorzugte Ausführungsform der vorliegenden Erfindung sind mithin gegen Kopfschuppen anzuwendende Formulierungen, beispielsweise Antischuppen- shampoos.A further preferred embodiment of the present invention are therefore formulations to be used against dandruff, for example antidandruff shampoos.
Erfindungsgemäß werden die Wirkstoffe bevorzugt in kosmetischen oder dermatologi- sehen Zusammensetzungen eingesetzt einem Gehalt von 0,0005 - 50,0 Gew.-%, insbesondere 0,01 - 20,0 Gew.-%, bezogen auf das Gesamtgewicht der Zusammensetzung bevorzugt sind. Vorteilhaft enthalten die Zusammensetzungen 0,02 - 10,0 Gew.- %, besonders bevorzugt 0,02 - 5,0 Gew.-% an den erfindungsgemäß verwendeten Wirkstoffen, ganz besonders vorteilhaft 0,1 - 3,0 Gew.-%, jeweils bezogen auf das Ge- samtgewicht der Zusammensetzung. Es kann erfindungsgemäß vorteilhaft sein, den Zubereitungen gemäß der Erfindung weitere gegen Sebum wirksame Agentien zuzufügen, beispielsweise gewählt aus der Gruppe Distärkephosphat, Cyclodextrin, Nat um-Maisstärke-Octylensuccinat, Silica- Dimethyl-Silylat, Hydroxypropyl-Distärkephosphate, Tapioca-Dextrin, Aluminium- Stärke-Octylensuccinat, Acrylat-Copolymer, Magnesiumcarbonat, Maisstärke, Alumi- nium-Stärke-Octylensuccinate, Kaolin, Nylon (z.B. Nylon 6/12), Bentonit, Natrium-Sili- coaluminat, Bornitrid, Silica, Glimmer + Titandioxid. Ferner kann es von Vorteil sein die erfindungsgemäßen Wirkstoffe zu verkapseln, z. B. als sogenannte solid lipid nanoparts mit Hilfe von aufgeschmolzenen Wachsen, die unter anderem, aber nicht ausschließlich, gewählt sein können aus der Gruppe der Esterwachse, Triglyceridwachse oder Kohlenwasserstoffwachse. Weiterhin kann es von Vorteil sein die erfindungsgemäßen Wirkstoffe in Polymere zu verkapseln, z. B. in Partikel auf Basis hochvernetzter Polymethacrylate und/oder Cellulosetriacetate und/oder als Core/Shell - Partikel mit einer Hülle aus Poly(oxymethylurea), Nylon, Polyamide, Polyurethan, Polyester, Gelatine und Polyolefine.According to the invention, the active ingredients are preferably used in cosmetic or dermatological compositions with a content of 0.0005-50.0% by weight, in particular 0.01-20.0% by weight, based on the total weight of the composition, being preferred. The compositions advantageously contain 0.02-10.0% by weight, particularly preferably 0.02-5.0% by weight of the active ingredients used according to the invention, very particularly advantageously 0.1-3.0% by weight, each based on the total weight of the composition. It can be advantageous according to the invention to add further agents which act against sebum to the preparations according to the invention, for example selected from the group of starch phosphate, cyclodextrin, sodium um maize starch octylene succinate, silica-dimethyl silylate, hydroxypropyl distarch phosphate, tapioca dextrin, aluminum Starch octylene succinate, acrylate copolymer, magnesium carbonate, maize starch, aluminum starch octylene succinate, kaolin, nylon (eg nylon 6/12), bentonite, sodium silicoaluminate, boron nitride, silica, mica + titanium dioxide. Furthermore, it may be advantageous to encapsulate the active compounds according to the invention, for. B. as a so-called solid lipid nanoparts with the help of melted waxes, which, among other things, but not exclusively, can be selected from the group of ester waxes, triglyceride waxes or hydrocarbon waxes. Furthermore, it may be advantageous to encapsulate the active compounds according to the invention in polymers, for. B. in particles based on highly cross-linked polymethacrylates and / or cellulose triacetates and / or as core / shell particles with a shell made of poly (oxymethylurea), nylon, polyamides, polyurethane, polyester, gelatin and polyolefins.
Die Kombination einzelner oder mehrerer Substanzen, gewählt aus der vorstehenden Gruppe, mit den erfindungsgemäß eingesetzten Hopfen- bzw. Hopfen-Malz-Extrakten führt zu synergistischer Verstärkung der Wirkung der Einzelsubstanzen und weist somit eigenständige Erfindungshöhe auf.The combination of one or more substances, selected from the above group, with the hop or hop-malt extracts used according to the invention leads to a synergistic enhancement of the effect of the individual substances and thus has an independent inventive step.
Die erfindungsgemäß verwendeten Wirkstoffe lassen sich ohne Schwierigkeiten in gängige kosmetische oder dermatologische Formulierungen einarbeiten, vorteilhaft in Pumpsprays, Aerosolsprays, Cremes, Salben, Tinkturen, Lotionen, Sticks, Waschprodukten und dergleichen.The active ingredients used according to the invention can be incorporated into common cosmetic or dermatological formulations without difficulty, advantageously in pump sprays, aerosol sprays, creams, ointments, tinctures, lotions, sticks, washing products and the like.
Es ist auch möglich und gegebenenfalls vorteilhaft, die erfindungsgemäß verwendeten Wirkstoffe mit anderen Wirkstoffen zu kombinieren, beispielsweise mit anderen antimi- krobiell, antimycotisch bzw. antiviral wirksamen Stoffen.It is also possible and possibly advantageous to combine the active substances used according to the invention with other active substances, for example with other antimicrobial, antimycotic or antiviral substances.
Es ist vorteilhaft, die erfindungsgemäßen Zusammensetzungen abzupuffern. Vorteilhaft ist ein pH-Bereich von 3,0 - 9,0. Besonders günstig ist es, den pH-Wert in einem Bereich von 4,0 - 6,5 zu wählen. Die erfindungsgemaßen kosmetischen und/oder dermatologischen Formulierungen können wie üblich zusammengesetzt sein und zur Behandlung der Haut und/oder der Haare im Sinne einer dermatologischen Behandlung oder einer Behandlung im Sinne der pflegenden Kosmetik dienen Sie können aber auch in Schminkprodukten in der dekorativen Kosmetik eingesetzt werdenIt is advantageous to buffer the compositions according to the invention. A pH range from 3.0 to 9.0 is advantageous. It is particularly favorable to choose the pH in a range from 4.0 to 6.5. The cosmetic and / or dermatological formulations according to the invention can be composed as usual and can be used to treat the skin and / or the hair in the sense of a dermatological treatment or a treatment in the sense of nourishing cosmetics. They can also be used in make-up products in decorative cosmetics
Zur Anwendung werden die erfindungsgemaßen kosmetischen und/oder dermatologischen Formulierungen in der für Kosmetika und Dermatika üblichen Weise auf die Haut und/oder die Haare in ausreichender Menge aufgebrachtFor use, the cosmetic and / or dermatological formulations according to the invention are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics and dermatics
Erfindungsgemaß können Zubereitungen, welche die erfindungsgemaßen Wirkstoff- kombinationen enthalten, übliche Antioxidantien eingesetzt werdenPreparations which contain the active compound combinations according to the invention and conventional antioxidants can be used according to the invention
Vorteilhaft werden die Antioxidantien gewählt aus der Gruppe bestehend aus Amino- sauren (z B Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z B Urocaninsaure) und deren Derivate, Peptide wie D,L-Carnosιn, D-Carnosin, L-Carno- sin und deren Derivate (z B Anserin), Carotinoide, Carotine (z B α-Carotin, ß-Carotin, Lycopin, Phytoen) und deren Derivate, Liponsaure und deren Derivate (z B Dihydroh- ponsaure), Aurothioglucose, Propylthiouracil und andere Thiole (z B Thioredoxin, Glu- tathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Pro- pyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, γ-Linoleyl-, Cholesteryl- und Glyce- rylester) sowie deren Salze, Dilaurylthiodipropionat, Distearylthiodipropionat, Thiodi- propionsaure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleo- side und Salze) sowie Sulfoximinverbindungen (z B Buthioninsulfoximine, Homocyste- insulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen vertraglichen Dosierungen (z B pmol bis μmol/kg), ferner (Metall)-Chelatoren (z B α- Hydroxyfettsauren, Palmitinsaure, Phytinsaure, Lactofer n), α-Hydroxysauren (z B Ci- tronensaure, Milchsäure, Apfelsaure), Tetrahydrocurcumin, Hummsaure, Gallensaure, Gallenextrakte, Bihrubin, Biliverdin, EDTA, EGTA und deren Derivate, ungesättigte Fettsauren und deren Derivate (z B γ-Linolensaure, Linolsaure, Olsaure), Folsaure und deren Derivate, Alanindiessigsaure, Flavonoide, Polyphenole, Catechine, Vitamin C und Derivate (z B Ascorbylpalmitat, Mg-Ascorbylphosphat, Ascorbylacetat), Toco- pherole und Derivate (z B Vitamin-E-acetat), sowie Koniferylbenzoat des Benzoehar- zes, Rutmsaure und deren Derivate, Ferulasaure und deren Derivate, Butylhydroxyto- luol, Butylhydroxyanisol, Nordihydroguajakharzsaure, Nordihydroguajaretsaure, Tri- hydroxybutyrophenon, Harnsaure und deren Derivate, Mannose und deren Derivate, Zink und dessen Derivate (z B ZnO, ZnSO4) Selen und dessen Derivate (z B Selen- methionin), Stilbene und deren Derivate (z B Stilbenoxid, Trans-Stilbenoxid) und die erfindungsgemaß geeigneten Derivate (Salze, Ester, Ether, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) dieser genannten WirkstoffeThe antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and its derivatives (eg anserine), carotenoids, carotenes (eg α-carotene, β-carotene, lycopene, phytoene) and their derivatives, lipoic acid and its derivatives (eg dihydro-ponic acid), aurothioglucose, Propylthiouracil and other thiols (e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl) , Oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds ( z. B. Buthioninsulfoximine, Homocyste- insulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathi oninsulfoximine) in very low contractual doses (e.g. pmol to μmol / kg), also (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactofer n), α-hydroxy acids (e.g. citric acid, lactic acid, Malic acid), tetrahydrocurcumin, humic acid, bile acid, bile extracts, bihrubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, alanine diacetic acid, polylaphenol diacid, poly Catechins, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. vitamin E acetate), as well as coniferyl benzoate of benzoic resin, ruthenic acid and its derivatives, ferulic acid and its derivatives, Butylhydroxyto-toluene, butylhydroxyanisole, nordihydroguajakharzsaure, nordihydroguajaretsaure, tri- hydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, zinc and its derivatives (eg ZnO, ZnSO 4 ) selenium and its derivatives (eg selenium methionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances
Die Menge der Antioxidantien (eine oder mehrere Verbindungen) in den Zubereitungen betragt vorzugsweise 0,001 bis 30 Gew -%, besonders bevorzugt 0,05 - 20 Gew - %, insbesondere 1 - 10 Gew -%, bezogen auf das Gesamtgewicht der ZubereitungThe amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 1 to 10% by weight, based on the total weight of the preparation
Die Prophylaxe bzw die kosmetische oder dermatologische Behandlung mit dem erfindungsgemaß verwendeten Wirkstoff bzw mit den kosmetischen oder topischen dermatologischen Zubereitungen mit einem wirksamen Gehalt an erfindungsgemaß verwendetem Wirkstoff erfolgt in der üblichen Weise, und zwar dergestalt, daß der erfin- dungsgemaß verwendete Wirkstoff bzw die kosmetischen oder topischen dermatologischen Zubereitungen mit einem wirksamen Gehalt an erfindungsgemaß verwendetem Wirkstoff auf die betroffenen Hautstellen aufgetragen wirdThe prophylaxis or the cosmetic or dermatological treatment with the active ingredient used according to the invention or with the cosmetic or topical dermatological preparations with an effective content of active ingredient used according to the invention is carried out in the customary manner, in such a way that the active ingredient used according to the invention or the cosmetic or topical dermatological preparations with an effective content of active ingredient used according to the invention is applied to the affected skin areas
Vorteilhaft kann der erfindungsgemaß verwendete Wirkstoff eingearbeitet werden in übliche kosmetische und dermatologische Zubereitungen, welche in verschiedenen Formen vorliegen können So können sie z B eine Losung, eine Emulsion vom Typ Wasser-ιn-OI (W/O) oder vom Typ Öl-in-Wasser (OΛ/V), oder eine multiple Emulsionen, beispielsweise vom Typ Wasser-m-öl-in-Wasser (W/O/W) oder Öl-in-Wasser-in- öl (OΛΛ//O), eine Hydrodispersion oder Lipodispersion, ein Gel, einen festen Stift oder auch ein Aerosol darstellenThe active ingredient used according to the invention can advantageously be incorporated into conventional cosmetic and dermatological preparations, which can be in various forms. For example, they can be a solution, an emulsion of the water-in-oil (W / O) type or of the oil-in type. Water (OΛ / V), or a multiple emulsions, for example of the type water-m-oil-in-water (W / O / W) or oil-in-water-in-oil (OΛΛ // O), a hydrodispersion or lipodispersion, a gel, a solid stick or an aerosol
Erfindungsgemaße Emulsionen im Sinne der vorliegenden Erfindung, z B in Form einer Creme, einer Lotion, einer kosmetischen Milch sind vorteilhaft und enthalten z B Fette, Öle, Wachse und/oder andere Fettkorper, sowie Wasser und einen oder mehre- re Emulgatoren, wie sie üblicherweise für einen solchen Typ der Formulierung verwendet werdenEmulsions according to the invention in the sense of the present invention, for example in the form of a cream, a lotion, a cosmetic milk, are advantageous and contain, for example, fats, oils, waxes and / or other fatty substances, as well as water and one or more emulsifiers such as them commonly used for such a type of formulation
Es ist auch möglich und vorteilhaft im Sinne der vorliegenden Erfindung, den erfindungsgemaß verwendeten Wirkstoff in wäßrige Systeme bzw Tensidzubereitungen zur Reinigung der Haut und der Haare einzufügen Es ist dem Fachmanne natürlich bekannt, daß anspruchsvolle kosmetische Zusammensetzungen zumeist nicht ohne die üblichen Hilfs- und Zusatzstoffe denkbar sind. Darunter zählen beispielsweise Konsistenzgeber, Füllstoffe, Parfüm, Farbstoffe, Emul- gatoren, zusätzliche Wirkstoffe wie Vitamine oder Proteine, Lichtschutzmittel, Stabilisatoren, Insektenrepellentien, Alkohol, Wasser, Salze, antimikrobiell, proteolytisch o- der keratolytisch wirksame Substanzen usw.It is also possible and advantageous for the purposes of the present invention to insert the active ingredient used according to the invention in aqueous systems or surfactant preparations for cleaning the skin and hair It is of course known to the person skilled in the art that sophisticated cosmetic compositions are usually inconceivable without the customary auxiliaries and additives. These include, for example, consistency agents, fillers, perfumes, dyes, emulsifiers, additional active ingredients such as vitamins or proteins, light stabilizers, stabilizers, insect repellents, alcohol, water, salts, antimicrobial, proteolytic or keratolytically active substances, etc.
Mutatis mutandis gelten entsprechende Anforderungen an die Formulierung medizini- scher Zubereitungen.Mutatis mutandis, corresponding requirements apply to the formulation of medical preparations.
Medizinische topische Zusammensetzungen im Sinne der vorliegenden Erfindung enthalten in der Regel ein oder mehrere Medikamente in wirksamer Konzentration. Der Einfachheit halber wird zur sauberen Unterscheidung zwischen kosmetischer und me- dizinischer Anwendung und entsprechenden Produkten auf die gesetzlichen Bestimmungen der Bundesrepublik Deutschland verwiesen (z.B. Kosmetikverordnung, Lebensmittel- und Arzneimittelgesetz).Medical topical compositions in the sense of the present invention generally contain one or more medicaments in an effective concentration. For the sake of simplicity, reference is made to the legal provisions of the Federal Republic of Germany (e.g. cosmetics regulation, food and drug law) for a clear distinction between cosmetic and medical use and corresponding products.
Es ist dabei ebenfalls von Vorteil, den erfindungsgemäß verwendeten Wirkstoff als Zu- satzstoff zu Zubereitungen zu geben, die bereits andere Wirkstoffe für andere Zwecke enthalten.It is also advantageous to add the active ingredient used according to the invention as an additive to preparations which already contain other active ingredients for other purposes.
Es ist beispielsweise vorteilhaft im Sinne der vorliegenden Erfindungen, einen Gehalt an UV-Schutzsubstanzen zu verwenden.For the purposes of the present invention, it is advantageous, for example, to use a content of UV protection substances.
Vorteilhaft können daher erfindungsgemäße Zubereitungen Substanzen enthalten, die UV-Strahlung im UVB-Bereich absorbieren, wobei die Gesamtmenge der Filtersubstanzen z.B. 0, 1 Gew.-% bis 30 Gew.-%, vorzugsweise 0,5 bis 10 Gew.-%, insbesondere 1 bis 6 Gew.-% beträgt, bezogen auf das Gesamtgewicht der Zubereitungen.Preparations according to the invention can therefore advantageously contain substances which absorb UV radiation in the UVB range, the total amount of filter substances e.g. 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1 to 6% by weight, based on the total weight of the preparations.
Die UVB-Filter können öllöslich oder wasserlöslich sein. Als öllösliche Substanzen sind z.B. zu nennen:The UVB filters can be oil-soluble or water-soluble. As oil-soluble substances e.g. to call:
3-Benzylidencampher und dessen Derivate, z.B. 3-(4-Methylbenzyliden)cam- pher, - 4-Aminobenzoesäure-Derivate, vorzugsweise 4-(Dimethylamino)-benzoesäure- (2-ethylhexyl)ester, 4-(Dimethylamino)benzoesäureamylester; Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure(2-ethylhexyl)ester, 4- Methoxyzimtsäureisopentylester;3-benzylidene camphor and its derivatives, for example 3- (4-methylbenzylidene) camphor, 4-aminobenzoic acid derivatives, preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester; Esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;
Ester der Salicylsäure, vorzugsweise Salicylsäure(2-ethylhexyl)ester, Salicylsäu- re(4-isopropylbenzyl)ester, Salicylsäurehomomenthylester;Esters of salicylic acid, preferably salicylic acid (2-ethylhexyl) ester, salicylic acid (4-isopropylbenzyl) ester, salicylic acid homomethyl ester;
Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy-4'-methylbenzophenon, 2,2'-Dihydroxy-4-methoxybenzo- phenon;Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzalmalonsäuredi(2- ethylhexyl)ester;Esters of benzalmalonic acid, preferably 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester;
2,4,6-Trianilino-(p-carbo-2'-ethyl-1 '-hexyloxy)-1 ,3,5-triazin.2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine.
Als wasserlösliche Substanzen sind vorteilhaft:The following are advantageous as water-soluble substances:
2-Phenylbenzimidazol-5-sulfonsäure und deren Salze, z.B. Natrium-, Kalium- o- der Triethanolammonium-Salze,2-phenylbenzimidazole-5-sulfonic acid and its salts, e.g. Sodium, potassium or triethanolammonium salts,
Sulfonsäure-Derivate von Benzophenonen, vorzugsweise 2-Hydroxy-4-methoxy- benzophenon-5-sulfonsäure und ihre Salze;Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid and their salts;
Sulfonsäure-Derivate des 3-Benzylidencamphers, wie z.B. 4-(2-Oxo-3-bornyli- denmethyl)benzolsulfonsäure, 2-Methyl-5-(2-pxo-3-bornylidenmethyl)sulfonsäure und ihre Salze.Sulfonic acid derivatives of 3-benzylidene camphor, e.g. 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid, 2-methyl-5- (2-pxo-3-bornylidenemethyl) sulfonic acid and their salts.
Die Liste der genannten UVB-Filter, die erfindungsgemäß Verwendung finden können, soll selbstverständlich nicht limitierend sein.The list of UVB filters mentioned, which can be used according to the invention, is of course not intended to be limiting.
Es kann auch von Vorteil sein, in erfindungsgemäßen Zubereitungen UVA-Filter einzusetzen, die üblicherweise in kosmetischen und/oder dermatologischen Zubereitungen enthalten sind. Bei solchen Filtersubstanzen handelt es sich vorzugsweise um Derivate des Dibenzoylmethans, insbesondere um 1-(4'-tert.Butylphenyl)-3-(4'-methoxyphe- nyl)propan-1 ,3-dion und um 1-Phenyl-3-(4'-isopropylphenyl)propan-1 ,3-dion. Auch Zu- bereitungen, die diese Kombinationen enthalten, sind Gegenstand der Erfindung. Es können die gleichen Mengen an UVA-Filtersubstanzen verwendet werden, welche für UVB-Filtersubstanzen genannt wurden.It can also be advantageous to use UVA filters in the preparations according to the invention, which are usually contained in cosmetic and / or dermatological preparations. Such filter substances are preferably derivatives of dibenzoylmethane, in particular 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione and 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione. Preparations containing these combinations are also the subject of the invention. The same amounts of UVA filter substances that were mentioned for UVB filter substances can be used.
Kosmetische und/oder dermatologische Zubereitungen im Sinne der vorliegenden Er- findung können auch anorganische Pigmente enthalten, die üblicherweise in der Kos- metik zum Schütze der Haut vor UV-Strahlen verwendet werden Dabei handelt es sich um Oxide des Titans, Zinks, Eisens, Zirkoniums, Sihciums, Mangans, Aluminiums, Cers und Mischungen davon, sowie Abwandlungen, bei denen die Oxide die aktiven Agentien sind Besonders bevorzugt handelt es sich um Pigmente auf der Basis von Titandioxid Es können die für die vorstehenden Kombinationen genannten Mengen verwendet werdenCosmetic and / or dermatological preparations in the sense of the present invention can also contain inorganic pigments which are usually used in cosmetics. Metics to protect the skin from UV rays are used. These are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, cerium and mixtures thereof, and modifications in which the oxides are the active agents are particularly preferred the pigments are based on titanium dioxide. The amounts mentioned for the above combinations can be used
Die erfindungsgemaß verwendeten kosmetischen und dermatologischen Zubereitungen können kosmetische Wirk-, Hilfs- und/oder Zusatzstoffe enthalten, wie sie ub - cherweise in solchen Zubereitungen verwendet werden, z B Antioxidationsmittel, Konservierungsmittel, Bakterizide, Parfüme, Substanzen zum Verhindern des Schäumens, Farbstoffe, Pigmente, die färbende Wirkung haben, Verdickungsmittel, oberflächenaktive Substanzen, Emulgatoren, weichmachende, anfeuchtende und/oder feuchthaltende Substanzen, Fette, öle, Wachse oder andere übliche Bestandteile etner kosme- tischen oder dermatologischen Formulierung wie Alkohole, Polyole, Polymere, Schaumstabihsatoren, Elektrolyte, organische Losungsmittel oder Si konderivateThe cosmetic and dermatological preparations used in accordance with the invention can contain cosmetic active ingredients, auxiliaries and / or additives of the kind normally used in such preparations, for example antioxidants, preservatives, bactericides, perfumes, substances for preventing foaming, dyes, pigments , which have a coloring effect, thickeners, surface-active substances, emulsifiers, softening, moisturizing and / or moisturizing substances, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic Solvents or silicon derivatives
Sofern die kosmetische oder dermatologische Zubereitung im Sinne der vorliegenden Erfindung eine Losung oder Emulsion oder Dispersion darstellt, können als Losungs- mittel verwendet werdenIf the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, solvents can be used
Wasser oder wäßrige LosungenWater or aqueous solutions
Ole, wie Tnglyceπde der Capπn- oder der Caprylsaure, vorzugsweise aber Rizinusöl, Fette, Wachse und andere natürliche und synthetische Fettkorper, vorzugsweise Ester von Fettsauren mit Alkoholen niedriger C-Zahl, z B mit Isopropanol, Pro- pylenglykol oder Glycenn, oder Ester von Fettalkoholen mit Alkansauren niedriger C-Zahl oder mit Fettsauren,Oils, such as Tnglyceπde the Capπn- or the caprylic acid, but preferably castor oil, fats, waxes and other natural and synthetic fatty substances, preferably esters of fatty acids with alcohols of low C number, for example with isopropanol, propylene glycol or Glycenn, or esters of Fatty alcohols with low C number alkane acids or with fatty acids,
Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Ethanol, Isopropanol, Propylenglykol, Glycenn, Ethylenglykol, Ethylenglykol- monoethyl- oder -monobutylether, Propylenglykolmonomethyl, -monoethyl- oderAlcohols, diols or polyols of low C number, and their ethers, preferably ethanol, isopropanol, propylene glycol, glycene, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or
-monobutylether, Diethylenglykolmonomethyl- oder -monoethylether und analoge Produkte-monobutyl ether, diethylene glycol monomethyl or monoethyl ether and similar products
Insbesondere werden Gemische der vorstehend genannten Losungsmittel verwendet Bei alkoholischen Losungsmitteln kann Wasser ein weiterer Bestandteil sein Die ölphase der Emulsionen, Oleogele bzw. Hydrodispersionen oder Lipodispersionen im Sinne der vorliegenden Erfindung wird vorteilhaft gewählt aus der Gruppe der Ester aus gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkan- carbonsäuren einer Kettenlänge von 3 bis 30 C-Atomen und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen, aus der Gruppe der Ester aus aromatischen Carbonsäuren und gesättigten und/oder ungesättigten, verzweigten und/oder unverzweigten Alkoholen einer Kettenlänge von 3 bis 30 C-Atomen. Solche Esteröle können dann vorteilhaft gewählt werden aus der Gruppe Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, Isopro- pyloleat, n-Butylstearat, n-Hexyllaurat, n-Decyloleat, Isooctylstearat, Isononylstearat, Isononylisononanoat, 2-Ethylhexylpalmitat, 2-Ethylhexyllaurat, 2-Hexyldecylstearat, 2- Octyldodecylpalmitat, Oleyloleat, Oleylerucat, Erucyloleat, Erucylerucat sowie synthetische, halbsynthetische und natürliche Gemische solcher Ester, z.B. Jojobaöl.In particular, mixtures of the abovementioned solvents are used. In the case of alcoholic solvents, water can be a further constituent The oil phase of the emulsions, oleogels or hydrodispersions or lipodispersions for the purposes of the present invention is advantageously selected from the group of esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 carbon atoms atoms. Such ester oils can then advantageously be chosen from the group of isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononylisononanoate, 2-ethyl-2-ethylhexyl, ethyl-2-ethylhexyl, ethyl-2-ethylhexyl 2- octyldodecyl palmitate, oleyl oleate, olerlerucate, erucyl oleate, erucylerucate as well as synthetic, semi-synthetic and natural mixtures of such esters, for example jojoba oil.
Ferner kann die ölphase vorteilhaft gewählt werden aus der Gruppe der verzweigten und unverzweigten Kohlenwasserstoffe und -wachse, der Silkonöle, der Dialkylether, der Gruppe der gesättigten oder ungesättigten, verzweigten oder unverzweigten Alkohole, sowie der Fettsäuretriglyceride, namentlich der Triglycehnester gesättigter und/oder ungesättigter, verzweigter und/oder unverzweigter Alkancarbonsäuren einer Kettenlänge von 8 bis 24, insbesondere 12 - 18 C-Atomen. Die Fettsäuretriglyceride können beispielsweise vorteilhaft gewählt werden aus der Gruppe der synthetischen, halbsynthetischen und natürlichen Öle, z.B. Olivenöl, Sonnenblumenöl, Sojaöl, Erdnußöl, Rapsöl, Mandelöl, Palmöl, Kokosöl, Palmkernöl und dergleichen mehr.Furthermore, the oil phase can advantageously be selected from the group of branched and unbranched hydrocarbons and waxes, the silicone oils, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and also the fatty acid triglycerides, especially the triglycne esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 - 18 carbon atoms. The fatty acid triglycerides can, for example, advantageously be selected from the group of synthetic, semisynthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like.
Auch beliebige Abmischungen solcher Öl- und Wachskomponenten sind vorteilhaft im Sinne der vorliegenden Erfindung einzusetzen. Es kann auch gegebenenfalls vorteilhaft sein, Wachse, beispielsweise Cetylpalmitat, als alleinige Lipidkomponente der Ölphase einzusetzen.Any mixtures of such oil and wax components can also be used advantageously for the purposes of the present invention. It may also be advantageous to use waxes, for example cetyl palmitate, as the sole lipid component of the oil phase.
Vorteilhaft wird die ölphase gewählt aus der Gruppe 2-Ethylhexylisostearat, Octyldo- decanol, Isotridecylisononanoat, Isoeicosan, 2-Ethylhexylcocoat, C12.15-Alkylbenzoat, Capryl-Caprinsäure-triglycerid, Dicaprylylether.The oil phase is advantageously selected from the group consisting of 2-ethylhexyl isostearate, octyldecanol, isotridecyl isononanoate, isoeicosane, 2-ethylhexyl cocoate, C 12 . 15 alkyl benzoate, caprylic capric acid triglyceride, dicaprylyl ether.
Besonders vorteilhaft sind Mischungen aus Cι2.i5-Alkybenzoat und 2-Ethylhexyliso- stearat, Mischungen aus d25-Alkybenzoat und Isotridecylisononanoat sowie Mischungen aus C12.15-Alkybenzoat, 2-Ethylhexylisostearat und Isotridecylisononanoat.Mixtures of C 2 .i 5 alkylbenzoate and 2-ethylhexyl iso- are particularly advantageous. stearate, mixtures of d 25 alkylbenzoate and isotridecyl isononanoate and mixtures of C 12 . 15 alkylbenzoate, 2-ethylhexyl isostearate and isotridecyl isononanoate.
Von den Kohlenwasserstoffen sind Paraffinöl, Squalan und Squalen vorteilhaft im Sin- ne der vorliegenden Erfindung zu verwenden.Of the hydrocarbons, paraffin oil, squalane and squalene are advantageously used in the context of the present invention.
Vorteilhaft kann die Ölphase ferner einen Gehalt an cyclischen oder linearen Silikonölen aufweisen oder vollständig aus solchen Ölen bestehen, wobei allerdings bevorzugt wird, außer dem Silikonöl oder den Silikonölen einen zusätzlichen Gehalt an an- deren Ölphasenkomponenten zu verwenden.The oil phase can advantageously also contain cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or the silicone oils.
Vorteilhaft wird Cyclomethicon (Octamethylcyclotetrasiloxan) als erfindungsgemäß zu verwendendes Silikonöl eingesetzt. Aber auch andere Silikonöle sind vorteilhaft im Sinne der vorliegenden Erfindung zu verwenden, beispielsweise Hexamethylcyclotrisi- loxan, Polydimethylsiloxan, Poly(methylphenylsiloxan).Cyclomethicone (octamethylcyclotetrasiloxane) is advantageously used as the silicone oil to be used according to the invention. However, other silicone oils can also be used advantageously for the purposes of the present invention, for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
Besonders vorteilhaft sind ferner Mischungen aus Cyclomethicon und Isotridecylisononanoat, aus Cyclomethicon und 2-Ethylhexylisostearat.Mixtures of cyclomethicone and isotridecyl isononanoate, cyclomethicone and 2-ethylhexyl isostearate are also particularly advantageous.
Die wäßrige Phase der erfindungsgemäßen Zubereitungen enthält gegebenenfalls vorteilhaft Alkohole, Diole oder Polyole niedriger C-Zahl, sowie deren Ether, vorzugsweise Ethanol, Isopropanol, Propylenglykol, Glycerin, Ethylenglykol, Ethylenglykolmo- noethyl- oder -monobutylether, Propylenglykolmonomethyl, -monoethyl- oder -monobutylether, Diethylenglykolmonomethyl- oder -monoethylether und analoge Produkte, ferner Alkohole niedriger C-Zahl, z.B. Ethanol, Isopropanol, 1 ,2-Propandiol, Glycerin sowie insbesondere ein oder mehrere Verdickungsmittel, welches oder welche vorteilhaft gewählt werden können aus der Gruppe Siliciumdioxid, Aluminiumsilikate, Poly- saccharide bzw. deren Derivate, z.B. Hyaluronsäure, Xanthangummi, Hydroxypropyl- methylcellulose, besonders vorteilhaft aus der Gruppe der Polyacrylate, bevorzugt ein Polyacrylat aus der Gruppe der sogenannten Carbopole, beispielsweise Carbopole der Typen 980, 981 , 1382, 2984, 5984, jeweils einzeln oder in Kombination.The aqueous phase of the preparations according to the invention advantageously advantageously contains alcohols, diols or polyols of low C number, and also their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether , Diethylenglykolmonomethyl- or -monoethylether and analogous products, furthermore low C-number alcohols, eg Ethanol, isopropanol, 1, 2-propanediol, glycerol and in particular one or more thickeners, which one or more can advantageously be selected from the group consisting of silicon dioxide, aluminum silicates, polysaccharides or their derivatives, e.g. Hyaluronic acid, xanthan gum, hydroxypropyl methyl cellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the group of so-called carbopols, for example carbopoles of types 980, 981, 1382, 2984, 5984, each individually or in combination.
Erfindungsgemäß verwendete Gele enthalten üblicherweise Alkohole niedriger C-Zahl, z.B. Ethanol, Isopropanol, 1 ,2-Propandiol, Glycerin und Wasser bzw. ein vorstehend genanntes öl in Gegenwart eines Verdickungsmittels, das bei ölig-alkoholischen Ge- len vorzugsweise Siliciumdioxid oder ein Aluminiumsilikat, bei wäßrig-alkoholischen o- der alkoholischen Gelen vorzugweise ein Polyacrylat ist.Gels used according to the invention usually contain alcohols of low C number, for example ethanol, isopropanol, 1, 2-propanediol, glycerol and water or an oil mentioned above in the presence of a thickener which is used in the case of oily alcoholic len is preferably silicon dioxide or an aluminum silicate, in the case of aqueous-alcoholic or alcoholic gels it is preferably a polyacrylate.
Feste Stifte enthalten z.B. natürliche oder synthetische Wachse, Fettalkohole oder Fettsäureester.Fixed pens contain e.g. natural or synthetic waxes, fatty alcohols or fatty acid esters.
Übliche Grundstoffe, welche für die Verwendung als kosmetische Stifte im Sinne der vorliegenden Erfindung geeignet sind, sind flüssige Öle (z.B. Paraffinöle, Ricinusöl, I- sopropylmyristat), halbfeste Bestandteile (z.B. Vaseline, Lanolin), feste Bestandteile (z.B. Bienenwachs, Ceresin und Mikrokristalline Wachse bzw. Ozokerit) sowie hochschmelzende Wachse (z.B. Carnaubawachs, Candelillawachs)Common basic materials which are suitable for use as cosmetic sticks in the sense of the present invention are liquid oils (for example paraffin oils, castor oil, isopropyl myristate), semi-solid components (for example petroleum jelly, lanolin), solid components (for example beeswax, ceresin and microcrystallines) Waxes or ozokerite) and high-melting waxes (e.g. carnauba wax, candelilla wax)
Als Treibmittel für aus Aerosolbehältern versprühbare kosmetische und/oder dermatologische Zubereitungen im Sinne der vorliegenden Erfindung sind die üblichen be- kannten leichtflüchtigen, verflüssigten Treibmittel, beispielsweise Kohlenwasserstoffe (Propan, Butan, Isobutan) geeignet, die allein oder in Mischung miteinander eingesetzt werden können. Auch Druckluft ist vorteilhaft zu verwenden.Suitable blowing agents for cosmetic and / or dermatological preparations which can be sprayed from aerosol containers for the purposes of the present invention are the customary known volatile, liquefied blowing agents, for example hydrocarbons (propane, butane, isobutane), which can be used alone or in a mixture with one another. Compressed air can also be used advantageously.
Natürlich weiß der Fachmann, daß es an sich nichttoxische Treibgase gibt, die grund- sätzlich für die Verwirklichung der vorliegenden Erfindung in Form von Aerosolpräparaten geeignet wären, auf die aber dennoch wegen bedenklicher Wirkung auf die Umwelt oder sonstiger Begleitumstände verzichtet werden sollte, insbesondere Fluorkohlenwasserstoffe und Fluorchlorkohlenwasserstoffe (FCKW).Of course, the person skilled in the art knows that there are non-toxic propellant gases per se which would in principle be suitable for the implementation of the present invention in the form of aerosol preparations, but which should nevertheless be dispensed with because of their harmful effects on the environment or other accompanying circumstances, in particular fluorocarbons and Chlorofluorocarbons (CFCs).
Kosmetische Zubereitungen im Sinne der vorliegenden Erfindung können auch als Gele vorliegen, die neben einem wirksamen Gehalt am erfindungsgemäßen Wirkstoff und dafür üblicherweise verwendeten Lösungsmitteln, bevorzugt Wasser, noch organische Verdickungsmittel, z.B. Gummiarabikum, Xanthangummi, Natriumalginat, Cellu- lose-Derivate, vorzugsweise Methylcellulose, Hydroxymethylcellulose, Hydroxyethyl- cellulose, Hydroxypropylcellulose, Hydroxypropylmethylcellulose oder anorganische Verdickungsmittel, z. B. Aluminiumsilikate wie beispielsweise Bentonite, oder ein Gemisch aus Polyethylenglykol und Polyethylenglykolstearat oder -distearat, enthalten. Das Verdickungsmittel ist in dem Gel z.B. in einer Menge zwischen 0,1 und 30 Gew.- %, bevorzugt zwischen 0,5 und 15 Gew.-%, enthalten. Die folgenden Beispiele sollen die Verkörperungen der vorliegenden Erfindungen verdeutlichen. Die Angaben beziehen sich stets auf Gewichts-%, sofern nicht andere Angaben gemacht werden. Cosmetic preparations in the sense of the present invention can also be present as gels which, in addition to an effective content of the active ingredient according to the invention and solvents usually used for this purpose, preferably water, and also organic thickeners, for example gum arabic, xanthan gum, sodium alginate, cellulose derivatives, preferably methyl cellulose, Hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose or inorganic thickeners, e.g. B. aluminum silicates such as bentonite, or a mixture of polyethylene glycol and polyethylene glycol stearate or distearate. The thickener is contained in the gel, for example, in an amount between 0.1 and 30% by weight, preferably between 0.5 and 15% by weight. The following examples are intended to illustrate the embodiment of the present invention. The information always refers to% by weight, unless other information is given.
4. Beispiel (Gelcreme):4. Example (gel cream):
Massengehalt (%)Mass content (%)
Acrylates/C 10-30 Alkyl Acrylate 0.40Acrylates / C 10-30 alkyl acrylates 0.40
CrosspolymerCrosspolymer
Carbomer 0.20Carbomer 0.20
Xanthan Gum 0.10Xanthan gum 0.10
Cetearyl Alkohol 3.00Cetearyl alcohol 3.00
C12-15 Alkyl Benzoate 4.00C12-15 alkyl benzoates 4.00
Caprylic/Capric Triglyceride 3.00Caprylic / Capric Triglyceride 3.00
Cyclometicone 5.00Cyclometicone 5.00
Dimeticone 1.00Dimeticone 1.00
Hopfen- bzw. Hopfen-Malz-Extrakt 0.20Hop or hop malt extract 0.20
Glycerin 3.00Glycerin 3.00
Natriumhydroxid q.s.Sodium hydroxide q.s.
Konservierung q s.Conservation q p.
Parfüm q.s.Perfume q.s.
Wasser.demineralisiert ad 100.0 pH-Wert eingestellt auf 6.0Water demineralized from 100.0 pH set to 6.0
Beispiel (W/O-Creme )Example (W / O cream)
Lameform TGI 3.50Lameform TGI 3.50
Glycerin 3.00Glycerin 3.00
Dehymuls PGPH 3.50Dehymuls PGPH 3.50
Hopfen- bzw. Hopfen-Malz-Extrakt 0.50Hop or hop malt extract 0.50
Konservierungsmittel q.s.Preservatives q.s.
Parfüm q.s.Perfume q.s.
Magnesiumsulfat 0.6Magnesium sulfate 0.6
Isopropyl Stearate 2.0Isopropyl stearate 2.0
Caprylyl Ether 8.0Caprylyl ether 8.0
Cetearyl Isononanoate 6.0Cetearyl isononanoate 6.0
Wasser, demin. ad 100.0 Beispiel (W/O W-Creme):Water, demin. ad 100.0 Example (W / O W cream):
Massengehalt (%)Mass content (%)
Glyceryl Stearate 3.00Glyceryl stearate 3.00
PEG-100 Stearate 0.75 Behenylalkohol 2.00PEG-100 stearate 0.75 behenyl alcohol 2.00
Caprylic/Capric Triglyceride 8.0Caprylic / Capric Triglyceride 8.0
Octyldodecanol 5.00Octyldodecanol 5.00
C12-15 Alkyl Benzoate 3.00C12-15 alkyl benzoates 3.00
Hopfen- bzw. Hopfen-Malz-Extrakt 1 ,00 Magnesium Sulfat (MgSO4) 0.80Hop or hop malt extract 1.00 magnesium sulfate (MgSO 4 ) 0.80
EDTA 0.10EDTA 0.10
Konservierung q.s.Conservation q.s.
Parfüm q.s.Perfume q.s.
Wasser.demineralisiert ad 100.0 pH-Wert eingestellt auf 6.0 Water demineralized from 100.0 pH set to 6.0

Claims

Patentansprüche: claims:
1. Verwendung eines Hopfen- bzw. Hopfen-Malz-Extraktes zur Herstellung von Zubereitungen zur Verminderung der Produktion von Sebum und zur Reduktion der Poren- große der Haut.1. Use of a hop or hop malt extract for the preparation of preparations for reducing the production of sebum and for reducing the pore size of the skin.
2. Verwendung nach Anspruch 1 zur Einstellung einer normalen Sebumhomeostase und/oder zur Behandlung und Pflege fettiger, öliger und unreiner Haut.2. Use according to claim 1 for the adjustment of normal sebum homeostasis and / or for the treatment and care of oily, oily and impure skin.
3. Verwendung nach Anspruch 1 zur Verhinderung der Bildung und zur Entfernung von Comedonen sowie zur Prophylaxe vor und Behandlung von Akne.3. Use according to claim 1 for preventing the formation and removal of comedones and for the prophylaxis before and treatment of acne.
4. Verwendung nach Anspruch 1 zur Verhinderung oder Beseitigung von seborrhoischen Erscheinungen, insbesondere zur Prophylaxe und Behandlung bei fettigem Haar, aber auch bei Kopfschuppen.4. Use according to claim 1 for the prevention or elimination of seborrheic phenomena, in particular for the prophylaxis and treatment of oily hair, but also in dandruff.
5. Kosmetisches Verfahren zur Prophylaxe gegen und Behandlung und Pflege von unreiner, fettiger und öliger Haut, seborrhoischen Erscheinungen, Reduktion der Porengröße, Comedonen, Akne, insbesondere fettigem Haar und/oder Kopfschuppen, da- durch gekennzeichnet, daß der Hopfen- bzw. Hopfen-Malz-Extrakt in einem geeigneten kosmetischen oder dermatologischen Träger, mit dem von gesteigerte Sebum- produktion betrof enen Bereich in Kontakt gebracht werden.5. Cosmetic method for the prophylaxis against and treatment and care of impure, oily and oily skin, seborrheic phenomena, reduction in pore size, comedones, acne, in particular oily hair and / or dandruff, characterized in that the hops or hops -Malt extract in a suitable cosmetic or dermatological carrier with which the area affected by increased sebum production is brought into contact.
6. Verwendung nach Anspruch 1 oder Verfahren nach Anspruch 5, dadurch gekenn- zeichnet, daß der Hopfen- bzw. Hopfen-Malz-Extrakt eingesetzt wird, einem Gehalt von 0,0005 - 50,0 Gew.-%, insbesondere 0,01 - 20,0 Gew.-%, entsprechend, bezogen auf das Gesamtgewicht der Zusammensetzung.6. Use according to claim 1 or method according to claim 5, characterized in that the hop or hop malt extract is used, a content of 0.0005 - 50.0 wt .-%, in particular 0.01 - 20.0 wt .-%, accordingly, based on the total weight of the composition.
7. Verwendung nach Anspruch 1 oder Verfahren nach Anspruch 5, dadurch gekenn- zeichnet, daß der Hopfen- bzw. Hopfen-Malz-Extrakt eingesetzt wird, einem Gehalt von 0,02 - 10,0 Gew.-%, bevorzugt 0,02 - 5,0 Gew.-%, besonders vorteilhaft 0,1 - 3,0 Gew.-%, entsprechend, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung. 7. Use according to claim 1 or method according to claim 5, characterized in that the hop or hop malt extract is used, a content of 0.02-10.0 wt .-%, preferably 0.02 - 5.0 wt .-%, particularly advantageously 0.1 - 3.0 wt .-%, accordingly, each based on the total weight of the composition.
8. Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Hopfenbzw. Hopfen-Malz-Extrakt.8. Cosmetic or dermatological preparations containing hops or Hop-malt extract.
9. Zubereitungen nach Anspruch 8, dadurch gekennzeichnet, daß der Hopfen- bzw. Hopfen-Malz-Extrakt eingesetzt wird, einem Gehalt von 0,0005 - 50,0 Gew.-%, insbesondere 0,01 - 20,0 Gew.-%, entsprechend, bezogen auf das Gesamtgewicht der Zusammensetzung.9. Preparations according to claim 8, characterized in that the hop or hop malt extract is used, a content of 0.0005 - 50.0 wt .-%, in particular 0.01 - 20.0 wt .-% %, corresponding to the total weight of the composition.
10. Zubereitungen nach Anspruch 8, dadurch gekennzeichnet, daß der Hopfen- bzw. Hopfen-Malz-Extrakt eingesetzt wird, einem Gehalt von 0,02 - 10,0 Gew.-%, bevorzugt10. Preparations according to claim 8, characterized in that the hop or hop malt extract is used, a content of 0.02 - 10.0 wt .-%, preferably
0,02 - 5,0 Gew.-%, besonders vorteilhaft 0,1 - 5,0 Gew.-%, entsprechend, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung. 0.02 - 5.0% by weight, particularly advantageously 0.1 - 5.0% by weight, correspondingly, in each case based on the total weight of the composition.
EP02740431A 2001-03-23 2002-03-21 Cosmetic and dermatological preparations comprising a hop extract or hop-malt extract and their use for reducing the sebum content of the skin Withdrawn EP1383473A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10114304A DE10114304A1 (en) 2001-03-23 2001-03-23 Cosmetic and dermatological preparations containing hops or hops-malt extract and use of a hop or hops malt extract for the preparation of cosmetic and dermatological preparations for the reduction of the sebum content of the skin
DE10114304 2001-03-23
PCT/EP2002/003178 WO2002076410A2 (en) 2001-03-23 2002-03-21 Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract

Publications (1)

Publication Number Publication Date
EP1383473A2 true EP1383473A2 (en) 2004-01-28

Family

ID=7678730

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02740431A Withdrawn EP1383473A2 (en) 2001-03-23 2002-03-21 Cosmetic and dermatological preparations comprising a hop extract or hop-malt extract and their use for reducing the sebum content of the skin

Country Status (4)

Country Link
US (1) US20040141938A1 (en)
EP (1) EP1383473A2 (en)
DE (1) DE10114304A1 (en)
WO (1) WO2002076410A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20060122A1 (en) * 2006-01-25 2007-07-26 Polichem Sa COMPOSITIONS FOR VAGINAL USE
US8071136B2 (en) * 2006-04-21 2011-12-06 Bioactives, Inc. Water-soluble pharmaceutical compositions of hops resins
US10265407B2 (en) 2007-02-15 2019-04-23 Yale University Modular nanodevices for smart adaptable vaccines
EP2262468B1 (en) 2008-03-25 2012-09-12 Mary Kay, Inc. Sebum absorption compositions
DE102009026414A1 (en) * 2009-05-22 2010-11-25 Henkel Ag & Co. Kgaa Skin treatment for pore refining

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148873A (en) * 1976-11-05 1979-04-10 S. S. Steiner, Inc. Method for treating the skin with extracts of hops
US4170638A (en) * 1976-11-05 1979-10-09 S. S. Steiner, Inc. Method for producing a deodorant
DE2749274A1 (en) * 1976-11-05 1978-05-11 Steiner Inc S S Bacteriostatic deodorant compsn., e.g. soap, contg. hop extract - which is opt. free of humulone and is used for eliminating or masking body odour
SU1472068A1 (en) * 1986-02-17 1989-04-15 Научно-производственное объединение "Аэрозоль" Agent for treating hair-covered skin to the head
DE3712986A1 (en) * 1987-04-16 1988-10-27 Marbert Gmbh MEDICAL PREPARATIONS BASED ON TREASURE EXTRACT, METHOD FOR THE PRODUCTION THEREOF AND USE OF TREATMENT EXTRACT FOR THE PRODUCTION OF COSMETIC PREPARATIONS AND A SPECIAL TREATMENT EXTRACT
SU1600774A1 (en) * 1988-12-19 1990-10-23 Рижское производственное объединение парфюмерно-косметической промышленности "Дзинтарс" Hair washing agent
JPH0647554B2 (en) * 1990-05-09 1994-06-22 株式会社ノエビア Testosterone 5α-reductase inhibitor
RU2033145C1 (en) * 1991-11-22 1995-04-20 Илья Залманович Герчиков Hair care agent
JP3805798B2 (en) * 1993-05-28 2006-08-09 株式会社コーセー Cosmetics
DE4419783A1 (en) * 1994-06-06 1995-12-07 Asta Medica Ag Medicated shampoo for hair care and treatment
ES2103198B1 (en) * 1995-08-09 1998-10-01 Cabo Soler Jose NEW COSMETIC AND PHARMACEUTICAL FORMULATION OF ANTI-ANDROGENS OF NATURAL ORIGIN (VEGETABLE) FOR TOPICAL PERCUTANEOUS APPLICATION.
DE29607212U1 (en) * 1996-04-20 1997-08-21 Goldwell Gmbh Coloring and tinting preparations for human hair
FR2753374B1 (en) * 1996-09-19 2000-01-14 Rivadis Lab COSMETIC COMPOSITION COMPRISING AT LEAST ONE PLANT EXTRACT, PEROXIDATED VEGETABLE OILS FOR THE SKIN
DE19729852A1 (en) * 1997-07-11 1999-09-09 Feil Mosquito repellant comprising beer, effective against malarial mosquitos
JPH1179948A (en) * 1997-09-12 1999-03-23 Noevir Co Ltd Hair tonic and hair cosmetic, and preparation for external use for skin for suppressing sebum secretion
BE1011858A7 (en) * 1998-04-01 2000-02-01 Raquet Jean Paul Phytocosmetic and phytodermatological external body care product production method
DE19815338C1 (en) * 1998-04-06 1999-09-09 Goldwell Gmbh Time- and energy saving production of stable aqueous hair color emulsions
KR100378733B1 (en) * 1998-09-23 2003-07-18 김혜숙 Method for using malt taffy to remove sebum
DE19858670C2 (en) * 1998-12-18 2001-07-12 Heinz Kasik Means for the care of skin, nails and hair and for the promotion of hair growth
FR2787711B1 (en) * 1998-12-29 2002-12-06 C3D Sarl COSMETIC COMPOSITION WITH DEPIGMENTING ACTIVITY AND ITS USE
KR100360915B1 (en) * 1999-12-02 2002-11-23 이옥이 A process for preparation of detergent for skin-pores
DE10008895A1 (en) * 2000-02-25 2001-08-30 Beiersdorf Ag Stabilization of active substances that are sensitive to oxidation and / or UV

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02076410A2 *

Also Published As

Publication number Publication date
WO2002076410A2 (en) 2002-10-03
WO2002076410A3 (en) 2003-09-25
DE10114304A1 (en) 2002-10-02
US20040141938A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
EP1296642B1 (en) Use of creatine and/or creatine derivatives in dermatological preparations
EP0945126B1 (en) Cosmetic or dermatologic composition containing carnitine and/or an acylcarnitine and at least an antioxidant
DE4444238A1 (en) Cosmetic or dermatological drug combinations of cinnamic acid derivatives and flavone glycosides
EP0687467A2 (en) Cosmetic and dermatological combinations containing glycerylalkylethers as active ingredients
EP1172084A2 (en) Cosmetic and dermatologic composition to eliminate sebum
EP1813255B1 (en) Stable combination of active agents containing glucose derivates and hydroxycarboxylic acids
DE10132338A1 (en) Use of 5'-deoxy-5'-methylthioadenosine in skin cosmetic products
EP1179338A1 (en) Cosmetic and dermatological compositions comprising cyclodextrines for removing sebum
DE19720339A1 (en) Treatment or prevention of undesired skin pigmentation
EP1733741A2 (en) O/W-emulsions comprising one or several bioquinones and an elevated amount of glycerine
DE19615575A1 (en) Use of glucosides and ferulic acid as an anti-irritative agent in cosmetic and topical dermatological preparations
WO2003011241A1 (en) Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations
EP1377254A2 (en) Cosmetic and dermatological preparations comprising an isoflavone content
DE10032165A1 (en) Use of physiologically tolerable sulfinic acids as antioxidant or free radical scavenger in cosmetic or dermatological preparations
DE19806946A1 (en) Combination of (acyl) carnitine and retinoid for use in skin care, effective e.g. against light-induced damage and inflammation
WO2005030157A1 (en) Cosmetic or dermatological preparations having a content of isoflavones and licochalcone a
WO2002098386A2 (en) Use of sodium polystyrene sulfonate for tightening skin
EP1383473A2 (en) Cosmetic and dermatological preparations comprising a hop extract or hop-malt extract and their use for reducing the sebum content of the skin
DE19615578A1 (en) Use of Salix nigra extract as an anti-irritant agent in cosmetic and topical dermatological preparations
DE10121069A1 (en) Use of tetrahydrocurcumin, tetrahydrodemethoxycurcumin and/or tetrahydrobisdemethoxycurcumin to prepare a cosmetic or dermatological composition for treating or preventing skin aging
DE19615576A1 (en) New mono: and di:glucoside of glabridin
DE102017210389A1 (en) Cosmetic preparations containing one or more alpha-hydroxycarboxylic acids and / or one or more beta-hydroxycarboxylic acids and / or one or more polyhydroxy acids, one or more distearates and starch
DE102004006829A1 (en) Cosmetic composition for e.g. preventing or treating acne or sebum production contains actives combination of isoflavones and antiperspirants
DE19739044A1 (en) Use of di:hydro-robinetin as antioxidant and/or radical scavenger
DE19615574A1 (en) Use of mono and/or di:glucoside(s) of gentisin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17P Request for examination filed

Effective date: 20040325

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 7/48 B

Ipc: 7A 61K 7/06 A

Ipc: 7A 61P 17/10 B

17Q First examination report despatched

Effective date: 20060626

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061107